Pilot Study Assessing Breast Temperature in Breast Cancer Patients

Sponsor
Duke University (Other)
Overall Status
Completed
CT.gov ID
NCT03376035
Collaborator
(none)
52
1
2
13.1
4

Study Details

Study Description

Brief Summary

Our investigators plan to measure the skin on the breast six months after breast reconstruction. The non-reconstructed breast will be used as the control for subject with unilateral reconstruction only. For those who have BILATERAL reconstruction, a core temperature will be obtained from the ear.

Condition or Disease Intervention/Treatment Phase
  • Other: Temperature measurement of breast
N/A

Detailed Description

Many factors influence outcomes following mastectomy and breast reconstruction. Cutaneous sensation, degree of scar formation, nipple projection and overall appearance are well correlated with patient satisfaction. However, very little data exists on the importance of skin temperature after mastectomy and reconstruction. Our investigators have noted that a number of patients report their reconstructed breast is cold and relate this as a source of dis-satisfaction. In these patients, it is unclear if 1) the reconstructed breast skin is cold and if so 2) can something can be done to improve this. Our investigators hypothesize that cutaneous breast temperature may be altered after mastectomy and reconstruction. This may be dependent on the reconstruction technique and other patient factors. In this pilot study, our investigators aim to establish techniques for evaluating cutaneous breast temperature following mastectomy and reconstruction. Our investigators hope to establish baseline data to develop an understanding of breast skin temperature after mastectomy and reconstruction.

Our long-term goals are to evaluate how cutaneous breast temperature may contribute to patient satisfaction. Our investigators also hope to determine which patients are at risk for developing a cold breast after surgery. Finally, our investigators will setup a prospective trial evaluating techniques to correct this problem and improve patient satisfaction.

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Determine skin temperature after breast reconstructionDetermine skin temperature after breast reconstruction
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot Study Assessing Cutaneous Breast Temperature in the Setting of Mastectomy and Reconstruction
Actual Study Start Date :
Dec 5, 2017
Actual Primary Completion Date :
Jan 7, 2019
Actual Study Completion Date :
Jan 7, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Unilateral breast reconstruction

Temperature measurements are obtained from the reconstructed breast and compared to the non-reconstructed breast.

Other: Temperature measurement of breast
Multiple measurements will be obtained from the ear, chest, breast, abdomen, and hands.

Experimental: Bilateral breast reconstruction

Temperature measurements are obtained from both reconstructed breasts and the core temperature is measured as well for comparison.

Other: Temperature measurement of breast
Multiple measurements will be obtained from the ear, chest, breast, abdomen, and hands.

Outcome Measures

Primary Outcome Measures

  1. Change in skin temperature after breast reconstruction [6 months after surgery]

    Temperature measurements

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • For post-reconstruction patients: all patients who have undergone mastectomy and breast reconstruction at Duke and are seen in clinic no sooner than 3 months after reconstruction and no more than 5 years after reconstruction.
Exclusion Criteria:
  • Metastatic malignancy of any kind.

  • Subjects with a history of breast implant augmentation prior to mastectomy and reconstruction.

  • Subjects who cannot give an informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27708

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: Scott Hollenbeck, MD, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT03376035
Other Study ID Numbers:
  • Pro00084743
First Posted:
Dec 18, 2017
Last Update Posted:
Jan 8, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of Jan 8, 2019